Table 1.
Demographic and clinical characteristics of the study population
| Training Set | Validation Set | P T-V | ||||||
|---|---|---|---|---|---|---|---|---|
| MCD | FSGS | P | MCD | FSGS | P | MCD | FSGS | |
| No. of subjects | 10 | 11 | 14 | 14 | ||||
| Age (years) | 39.5 (28.0 –68.0) | 57.0 (31.0 –71.0) | 0.57 | 55.5 (30.0 –72.0) | 54.5 (36.0 –59.0) | 0.45 | 0.32 | 0.85 |
| Female/male ratio | 3/7 | 5/6 | 0.47 | 6/8 | 2/12 | 0.09 | 0.52 | 0.08 |
| Body mass index (kg/m2) | 27.3 (21.9 –33.8) | 25.5 (24.0 –26.6) | 0.68 | 29.4 (24.2 –30.6) | 26.3 (25.1 –28.4) | 0.63 | 0.76 | 0.41 |
| Body surface area | 1.7 (1.7 –1. 9) | 1.8 (1.6 –1.8) | 0.83 | 1.8 (1.6 –1.9) | 1.9 (1.8 –2.0) | 0.35 | 0.52 | 0.11 |
| Serum glucose (mg/dl) | 91 (81–101) | 88 (83–97) | 0.89 | 84 (81–94) | 94 (87–97) | 0.19 | 0.44 | 0.67 |
| Serum protein (g/dl) | 4.4 (3.7 –4.7) | 5.0 (4.1 –6.2) | 0.09 | 4.7 (4.1 –4.9) | 6.1 (4.5 –6.3) | 0.05 | 0.29 | 0.56 |
| Serum creatinine (mg/dl) | 0.9 (0.8 –1.0) | 1.2 (0.9 –1.2) | 0.12 | 0.9 (0.8 –1.3) | 1.3 (0.9 –1.8) | 0.24 | 0.64 | 0.62 |
| Proteinuria (g/24 h) | 10.6 (2.3 –12.2) | 3.5 (2.5 –7.4) | 0.29 | 9.7 (5.9 –15.0) | 3.4 (1.7 –4.5) | 0.004 | 0.52 | 0.64 |
Data are shown as median (interquartile range)
Differences between groups were tested using the non-parametric Kruskall Wallis test. P T-V shows P value between training and validation set. P < 0.05 was considered significant